Merocyanine derivatives

US9550730B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9550730-B2
Application numberUS-201214232915-A
CountryUS
Kind codeB2
Filing dateJul 19, 2012
Priority dateJul 21, 2011
Publication dateJan 24, 2017
Grant dateJan 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are compounds of formula (1) and (2) and/or E/E-, E/Z- or Z/Z geometrical isomer forms thereof; wherein R1-R5, R1-R11 and A are defined as in description. The compounds are used as UV absorbers for protecting household products from photolytic and oxidative degradation, as plastic additives, preferably for food and pharmaceutical packaging applications, for preventing photo-degradation of food by incorporation of the compounds of formula (1′) and/or (2′) into transparent food containers, for protection of UV-A sensitive drugs from photo-degradation by incorporation of UV absorber in transparent blister foils or transparent pharmacy containers, as additives for photographic and printing applications, as additives for electronic applications and protecting the ingredients in agriculture applications.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula and/or its E/E-, E/Z- or Z/Z geometrical isomer forms; wherein R 1 and R 2 independently of each other are hydrogen; C 4 -C 12 alkyl; or hydroxyl-C 3 -C 12 alkyl; R 3 is a —(C═O)OR 6 group; or a —(CO)NHR 6 group; R 6 is C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkinyl, C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl, which is optionally substituted by one or more than one OH; R 4 and R 5 are hydrogen; or R 4 and R 5 form a —(CH 2 ) n — ring which is optionally interrupted by one or more than one —O— or by —NH—; n is a number from 2 to 7; R 7 and R 8 independently of each other are hydrogen; C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkinyl, which is interrupted by one or more than one O or substituted by one or more than one OH, C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl, wherein said C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl is optionally interrupted by one or more than one —O—; or R 7 and R 8 together with the nitrogen atom linking them form a —(CH 2 ) n — ring which is optionally interrupted by one or more than one —O—; R 9 and R 10 are hydrogen; or R 9 and R 10 form a —(CH 2 ) n — ring which is optionally interrupted by —O— or by —NH—; A is —O—; or —NH; R 11 is C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkinyl, C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl, which is optionally interrupted by one or more than one O; or C 1 -C 22 alkyl or C 2 -C 22 alkenyl which is substituted by C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl, wherein said C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl is optionally interrupted by one or more than one —O—; with the proviso that (I) at least one of R 1 , R 2 , and R 6 is substituted by hydroxyl; (II) if one of R 1 is hydroxyethyl, R 2 is not hydrogen, methyl or ethyl or hydroxyethyl; and if R 1 is hydrogen, R 2 is not 1-hydroxy-3-methyl-but-2-yl; (III) if R 6 is substituted by one or more than one OH; one of R 1 and R 2 is C 4 -C 22 alkyl; or R 1 and R 2 together with the linking nitrogen form a piperidyl or morpholinyl radical; and (IV) at least one of R 7 and R 8 , or R 11 is interrupted by one or more than one —O—. 2. The compound according to claim 1 , wherein R 1 and R 2 independently of each other are hydrogen; C 4 -C 12 alkyl; or hydroxyl-C 3 -C 12 alkyl; R 3 is a —(C═O)OR 6 group; or a —(CO)NHR 6 group; R 6 is C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkinyl, C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl, which is optionally substituted by one or more than one OH; R 4 and R 5 are hydrogen; or R 4 and R 5 form a —(CH 2 ) n — ring which is optionally interrupted by —O— or by —NH—; n is a number from 2 to 7; R 7 and R 8 independently of each other are hydrogen; C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkinyl, which is interrupted by one or more than one O or substituted by one or more than one OH; or R 7 and R 8 together with the nitrogen atom linking them form a —(CH 2 ) n — ring which is optionally interrupted by one or more than one —O—; R 9 and R 10 are hydrogen; or R 9 and R 10 form a —(CH 2 ) n — ring which is optionally interrupted by —O— or by —NH—; A is —O—; or —NH; R 11 is C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkinyl, C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl, which is optionally interrupted by one or more than one O; with the proviso that (I) at least one of R 1 , R 2 , and R 6 is substituted by hydroxyl; (II) if one of R 1 is hydroxyethyl, R 2 is not hydrogen, methyl or ethyl or hydroxyethyl; and if R 1 is hydrogen, R 2 is not 1-hydroxy-3-methyl-but-2-yl; (III) if R 6 is substituted by one or more than one OH; one of R 1 and R 2 is C 4 -C 22 alkyl; or R 1 and R 2 together with the linking nitrogen form a piperidyl or morpholinyl radical; and (IV) at least one of R 7 and R 8 , or R 1 is interrupted by one or more than one —O—. 3. A compound which corresponds to one of the following formulas 4. A compound which is 2-ethoxyethyl(2Z)-cyano{3-[(3-methoxypropyl)amino]cyclohex-2-en-1-ylidene}ethanoate in its E/Z geometrical isomer corresponding to the formula and/or its E/E geometrical form of formula 5. A compound of formula and/or its E/E-, E/Z- or Z/Z geometrical isomer forms; wherein R 1 and R 2 independently of each other are hydrogen; C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkinyl, which are optionally substituted by at least one hydroxyl; or R 1 and R 2 together with the nitrogen atom linking them form a —(CH 2 ) n — ring which is optionally interrupted by —O— or by —NH—; R 3 is a —(C═O)OR 6 group; or a —(CO)NHR 6 group; R 6 is C 1 -C 12 alkyl, which is optionally substituted by one or more than one hydroxyl; R 4 and R 5 are hydrogen; or R 4 and R 5 form a —(CH 2 ) n — ring which is optionally interrupted by one or more than one —O— or by —NH—; n is a number from 2 to 7; with the proviso that (I) at least one of R 1 , R 2 , and R 6 is substituted by hydroxyl; (II) if one of R 1 is hydroxyethyl, R 2 is not hydrogen, methyl or ethyl or hydroxyethyl; and if R 1 is hydrogen, R 2 is not 1-hydroxy-3-methyl-but-2-yl; and (III) if R 6 is substituted by one or more than one OH; one of R 1 and R 2 is C 4 -C 22 alkyl; or R 1 and R 2 together with the linking nitrogen form a piperidyl or morpholinyl radical. 6. The compound of formula (1) according to claim 5 , wherein one of R 1 and R 2 is C 4 -C 22 alkyl; or R 1 and R 2 together with the nitrogen atom linking them form a —(CH 2 ) n -ring which is optionally interrupted by —O— and/or —NH—. 7. A compound of formula and/or its E/E-, E/Z- or Z/Z geometrical isomer forms; wherein R 1 and R 2 respectively together with the linking nitrogen atom to form a piperidyl, radical, or a morpholinyl radical; R 3 is a —(C═O)OR 6 group; or a —(CO)NHR 6 group; R 6 is C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkinyl, C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl, which is optionally substituted by one or more than one OH; R 4 and R 5 are hydrogen; or R 4 and R 5 form a —(CH 2 ) n — ring which is optionally interrupted by one or more than one —O— or by —NH—; n is a number from 2 to 7; R 7 and R 8 respectively together with the linking nitrogen atom form a piperidyl radical or a morpholinyl radical; R 9 and R 10 are hydrogen; or R 9 and R 10 form a —(CH 2 ) n — ring which is optionally interrupted by —O— or by —NH—; A is —O—; or —NH; R 11 is C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkinyl, C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl, which is optionally interrupted by one or more than one O; or C 1 -C 22 alkyl or C 2 -C 22 alkenyl which is substituted by C 3 -C 22 cycloalkyl or C 3 -C 22 cycloalkenyl, wherein said C 3 -C 22 cycloalkyl or

Assignees

Inventors

Classifications

  • Radicals substituted by nitrogen atoms not forming part of a nitro radical · CPC title

  • Piperidines · CPC title

  • C07C255/30Primary

    containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same unsaturated acyclic carbon skeleton · CPC title

  • substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals · CPC title

  • Radicals substituted by nitrogen atoms (nitro radicals C07D317/16) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9550730B2 cover?
Disclosed are compounds of formula (1) and (2) and/or E/E-, E/Z- or Z/Z geometrical isomer forms thereof; wherein R1-R5, R1-R11 and A are defined as in description. The compounds are used as UV absorbers for protecting household products from photolytic and oxidative degradation, as plastic additives, preferably for food and pharmaceutical packaging applications, for preventing photo-degradatio…
Who is the assignee on this patent?
Winkler Barbara, Hueglin Dietmar, Eichin Kai, and 6 more
What technology area does this patent fall under?
Primary CPC classification C07C255/30. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).